Bellevue Group Ag Cytokinetics Inc Transaction History
Bellevue Group Ag
- $5.93 Billion
- Q3 2024
A detailed history of Bellevue Group Ag transactions in Cytokinetics Inc stock. As of the latest transaction made, Bellevue Group Ag holds 10,941 shares of CYTK stock, worth $541,141. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,941
Previous 16,659
34.32%
Holding current value
$541,141
Previous $902,000
36.03%
% of portfolio
0.01%
Previous 0.02%
Shares
9 transactions
Others Institutions Holding CYTK
# of Institutions
405Shares Held
125MCall Options Held
4.61MPut Options Held
2.46M-
Black Rock Inc. New York, NY14.7MShares$726 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$582 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD9.69MShares$479 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA7.77MShares$385 Million0.07% of portfolio
-
State Street Corp Boston, MA6.46MShares$319 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $4.66B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...